PULMI
AstraZeneca AB
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78527524 |
| Registration Number | 3437637 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | 2 |
| Domestic Representative | Wm. Charles Saunders |
| Attorney Name | Wm. Charles Saunders |
| Attorney Docket Number | PULMI |
| Law Office Assigned | M20 |
| Employee Name | LEHKER, DAWN FELDMAN |
Timeline
| 2003-08-00 | Date of First Use |
| 2004-12-06 | Application Filed |
| 2005-10-11 | Published for Opposition |
| 2008-04-21 | Location: PUBLICATION AND ISSUE SECTION |
| 2008-05-27 | Trademark Registered |
| 2015-01-02 | Cancelled |
| 2015-01-02 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  AstraZeneca AB |
| Address | Vastra Malarehamnen 9 Sodertalje SE SE-151 85 |
| Legal Entity Type | Corporation |
| Legal Entity State | SE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0441 | PROVIDING INFORMATION ABOUT TREATMENT AND MANAGEMENT OF ASTHMA |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2004-12-15 | 1 NWAP I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2005-07-11 | 2 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2005-07-11 | 3 CNSA P: |
| ASSIGNED TO LIE | 2005-07-15 | 4 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2005-07-19 | 5 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2005-09-21 | 6 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2005-10-11 | 7 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2006-01-03 | 8 NOAM O:Outgoing Correspondence |
| TEAS EXTENSION RECEIVED | 2006-06-27 | 9 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2006-06-27 | 10 EXT1 S: |
| EXTENSION 1 GRANTED | 2006-08-07 | 11 EX1G S: |
| TEAS EXTENSION RECEIVED | 2006-12-28 | 12 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2006-12-28 | 13 EXT2 S: |
| EXTENSION 2 GRANTED | 2007-03-09 | 14 EX2G S: |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2007-06-11 | 15 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2007-06-11 | 16 ARAA I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2007-06-29 | 17 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2007-06-29 | 18 EXT3 S: |
| EXTENSION 3 GRANTED | 2007-09-11 | 19 EX3G S: |
| FAX RECEIVED | 2008-01-03 | 20 FAXX I:Incoming Correspondence |
| EXTENSION 4 FILED | 2008-01-03 | 21 EXT4 S: |
| EXTENSION 4 GRANTED | 2008-01-28 | 22 EX4G S: |
| TEAS STATEMENT OF USE RECEIVED | 2008-03-11 | 23 EISU I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2008-03-11 | 24 TROA I:Incoming Correspondence |
| USE AMENDMENT FILED | 2008-03-11 | 25 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2008-03-31 | 26 SUPC I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2008-04-14 | 27 CNPR P: |
| ASSIGNED TO LIE | 2008-04-16 | 28 ALIE A:Allowance for Publication |
| LAW OFFICE REGISTRATION REVIEW COMPLETED | 2008-04-21 | 29 REGV O:Outgoing Correspondence |
| REGISTERED-PRINCIPAL REGISTER | 2008-05-27 | 30 R.PR A:Allowance for Publication |
| CANCELLED SEC. 8 (6-YR) | 2015-01-02 | 31 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 PULMI 78889344 not registered Dead/Abandoned |
AstraZeneca AB 2006-05-22 |
 PULMI 78527524 3437637 Dead/Cancelled |
AstraZeneca AB 2004-12-06 |
 PULMI 78289251 not registered Dead/Abandoned |
Astrazeneca Pharmaceuticals LP 2003-08-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 